Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Glob Public Health. 2014 Oct 27;10(1):71–87. doi: 10.1080/17441692.2014.967709

Figure 1.

Figure 1

Patients’ reasons for TAM use at different stages of ART

Note: *indicates patient failing ART regimen (vL>1000 copies/mL) after 5+ months of treatment. P1, P2, etc. each represent a distinct patient who reported ever using TAM in his or her lifetime. P1 indicates that she used TAM for HIV and non-HIV related reasons at different stages.